U.S. Markets closed

23andMe Holding Co. Class A Common Stock (ME)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
11.72-0.87 (-6.91%)
At close: 4:00PM EDT
11.88 +0.16 (1.37%)
After hours: 07:56PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close12.59
Bid11.81 x 1100
Ask11.88 x 800
Day's Range11.56 - 13.00
52 Week Range9.65 - 18.16
Avg. Volume1,207,513
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Industry Leaders Join 23andMe Board of Directors

    Industry Leaders Join 23andMe Board of Directors

    Dr. Valerie Montgomery Rice and Peter Taylor Join 23andMe’s Board as the Company Sets to Accelerate Personalized Healthcare Based on Human GeneticsSUNNYVALE, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, announced today that, following the June 16 closing of the previously announced business combination between 23andMe, Inc. and VG Acquisition Corp. (“VGAC”), Dr. Valerie Montgomery Rice, the president and

  • Yahoo Finance Video

    23andMe CEO on public debut, future of genetic testing

    DNA testing company 23andMe started trading on Thursday under the ticker ‘ME’. Anne Wojcicki, 23andMe CEO, joins Yahoo Finance Live to discuss the company going public and the future of genetic testing post-COVID.

  • Yahoo Finance Video

    23andMe goes public

    Myles Udland, Brian Sozzi, and Julie Hyman breakdown 23andMe going public with the help of Richard Branson, and how the company plans to change its business model to make itself more profitable in the market.